SCI Stock Recent News
SCI LATEST HEADLINES
Service Corp. (SCI) came out with quarterly earnings of $0.79 per share, missing the Zacks Consensus Estimate of $0.86 per share. This compares to earnings of $0.83 per share a year ago.
Conference call on Thursday, August 1, 2024, at 8:00 a.m. Central Time.
Service Corporation's (SCI) second-quarter 2024 performance will likely reflect gains from strength in the Cemetery segment. However, a rising interest rate environment poses a threat.
Service Corporation International has seen mixed financial results, with revenue declining in 2023 but rising in the first quarter of 2024. The company's cemetery operations performed well, while funeral gross profit and net income declined due to higher costs and interest expenses. Despite some negative financial metrics, the company is attractively priced and has long-term growth potential due to projected population growth and increasing death counts.
VIENNA, Va.--(BUSINESS WIRE)---- $CVM #Multikine--CEL-SCI's phase 3 population analysis for upcoming confirmatory registration study in head & neck cancer demonstrates well balanced patient population.
Service Corporation (SCI) benefits from strength in its Cemetery segment and a focus on strengthening its network.
HOUSTON , July 17, 2024 /PRNewswire/ -- Service Corporation International (NYSE: SCI) announced it expects to issue a press release with financial results for the second quarter 2024 on Wednesday, July 31, 2024. A conference call will be hosted by SCI Management on Thursday, August 1, 2024.
VIENNA, Va.--(BUSINESS WIRE)---- $CVM #Multikine--CEL-SCI Corporation (NYSE American: CVM) today announced the Company's Chief Scientific Officer, Dr. Eyal Talor, delivered a presentation titled “Neoadjuvant Immunotherapy for Head and Neck Cancer: Low Tumor PD-L1 Expression - IT-MATTERS – RCT” at the International Drug Discovery Science & Technology (IDDST) 20th Annual Congress in Budapest, Hungary on Tuesday, June 18, 2024. Dr. Talor presented during the Cancers/Tumors session which he Chaired along with Dr.
Service Corporation (SCI) gains from increased Cemetery segment revenues and a focus on making capital investments to strengthen its network.
VIENNA, Va.--(BUSINESS WIRE)---- $CVM #Multikine--Dr. Giovanni Selvaggi, who has brought several oncology drugs to market, joins CEL-SCI as Clinical Advisor.